Dr. Elizabeth Nabel's hospital is participating in the Cambridge biotech's trial of a COVID-19 vaccine. She recently sold stock in it worth nearly $6.5m
Dr. Elizabeth Nabel's hospital is participating in the Cambridge biotech's trial of a COVID-19 vaccine. She recently sold stock in it worth nearly $6.5m